NanoString Technologies Receives $30,000,000 Series C Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9c7b2c45-3cd4-4827-a736-5ddfb2deb728&Preview=1 -
Date
6/9/2009 -
Company Name
NanoString Technologies -
Mailing Address
530 Fairview Ave N Seattle, WA 98109 -
Company Description
NanoString™ Technologies is developing a patent pending platform for single molecule identification and digital quantification. The NanoString™ system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample. This cutting-edge technology is a truly broad based platform onto which many applications can be developed, in life sciences or other industries entirely. Applications include gene expression analysis, proteomics, molecular diagnostics and, in the future, predictive, preventative, and personalized medicine. -
Website
http://www.nanostring.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Series C -
Proceeds Purposes
NanoString’s new money will be used to help the company boost U.S. and international sales of nCounter, an instrument that’s supposed to give biologists a digital readout that says to what extent a given gene is dialed on or off in a tissue sample. -
M&A Terms
-
Venture Investor
Clarus Ventures -
Venture Investor
OVP Venture Partners -
Venture Investor
Draper Fisher Jurvetson
